The Clinical Trial Center North (CTC North) is consortium partner of the apoplexy project “Prevention of Complications to Improve Outcome in elderly patients with acute stroke (PRECIOUS)”, funded in the framework of EU research and innovation programme “Horizon 2020”,
Part of the project is a randomised clinical trial with 3,800 elderly patients with acute stroke, which is scheduled to take place in 80 clinical trial centres and hospitals in nine European countries. In co-operation with the University Medical Center Hamburg (UKE), the CTC North will be responsible for the overall study and the “safety monitoring” of the large clinical trial in Germany.
Opened as a full service CRO on the grounds of the UKE in November 2006, the CTC North runs a modernly equipped research wards for Phase I/II trials and conducts trials of the highest standards for the pharmaceutical and biotechnological industries. CTC North study ward is equipped with 26 beds, including six beds used for continuous cardiovascular monitoring,, and eleven PSG beds used for sleep research in collaboration with the University Medical Center Hamburg.
source and further details: